All Stories

  1. Establishment of four induced pluripotent stem cell lines with high polygenic risk score for Parkinson’s disease
  2. <i>Ex vivo</i> correction of severe coagulation Factor VII deficiency in patient-derived 3D liver organoids
  3. Effect of hypoxia on aquaporins and hepatobiliary transport systems in human hepatic cells
  4. Mechanical regulation of mitochondrial morphodynamics in cancer cells by extracellular microenvironment
  5. Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform
  6. Hallmark Molecular and Pathological Features of POLG Disease are Recapitulated in Cerebral Organoids
  7. Activation of Neurotoxic Astrocytes Due to Mitochondrial Dysfunction Triggered by POLG Mutation
  8. The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC derived Cortical Organoid of Alpers' Disease
  9. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation
  10. Cell line sourcing and characterization for cultured meat product development
  11. A loss-of-function mutation in human Oxidation Resistance 1 disrupts the spatial–temporal regulation of histone arginine methylation in neurodevelopment
  12. Scalable production of tissue-like vascularized liver organoids from human PSCs
  13. Deoxyribonucleoside treatment rescues EtBr‐induced mtDNA depletion in iPSC‐derived neural stem cells with POLG mutations
  14. Sensitivity of endogenous autofluorescence in HeLa cells to the application of external magnetic fields
  15. POLG genotype influences degree of mitochondrial dysfunction in iPSC derived neural progenitors, but not the parent iPSC or derived glia
  16. Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5’-untranslated region of UNC45A
  17. “iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives”
  18. “Organ-in-a-Column” Coupled On-line with Liquid Chromatography-Mass Spectrometry
  19. Comparing the mitochondrial signatures in ESCs and iPSCs and their neural derivations
  20. Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview
  21. POLG mutations lead to abnormal mitochondrial remodeling during neural differentiation of human pluripotent stem cells via SIRT3/AMPK pathway inhibition
  22. Autophagy modulates cell fate decisions during lineage commitment
  23. Distinct Mitochondrial Remodeling During Mesoderm Differentiation in a Human-Based Stem Cell Model
  24. 3D Printed Tooling for Injection Molded Microfluidics
  25. Nicotinamide Riboside and Metformin Ameliorate Mitophagy Defect in Induced Pluripotent Stem Cell-Derived Astrocytes With POLG Mutations
  26. Distinct mitochondrial remodeling during early cardiomyocyte development in a human-based stem cell model
  27. ADVANCED PRECLINICAL MODELS FOR EVALUATION OF DRUG INDUCED LIVER INJURY - CONSENSUS STATEMENT BY THE EUROPEAN DRUG-INDUCED LIVER INJURY NETWORK [PRO-EURO-DILI-NET]
  28. Liver Organoids: Recent Developments, Limitations and Potential
  29. Increased p53 signaling impairs neural differentiation in HUWE1-promoted intellectual disabilities
  30. N-acetylcysteine amide ameliorates mitochondrial dysfunction and reduces oxidative stress in hiPSC-derived dopaminergic neurons with POLG mutation
  31. Electromembrane Extraction and Mass Spectrometry for Liver Organoid Drug Metabolism Studies
  32. How well do brain organoids capture your brain?
  33. Stem cell derived astrocytes with POLG mutations and mitochondrial dysfunction including abnormal NAD+ metabolism is toxic for neurons
  34. Scalable production of tissue-like vascularised liver organoids from human PSCs
  35. Characterizing Coagulation FVII from iPSC-Hepatocytes-like Cells: Setting the Basis for Cell Therapy Development
  36. A method for differentiating human induced pluripotent stem cells toward functional cardiomyocytes in 96-well microplates
  37. “Organoid-in-a-column” coupled on-line with liquid chromatography-mass spectrometry
  38. Disease‐specific phenotypes in iPSC ‐derived neural stem cells with POLG mutations
  39. Scalable small molecule derived mini-liver organoids from human pluripotent stem cells
  40. Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons
  41. Electromembrane extraction and mass spectrometry for liver organoid drug metabolism studies
  42. Synthetic Analyses of Single-Cell Transcriptomes from Multiple Brain Organoids and Fetal Brain
  43. 3D cell culture models and organ‐on‐a‐chip: Meet separation science and mass spectrometry
  44. Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties
  45. Inflammation and Mechanical Stress Stimulate Osteogenic Differentiation of Human Aortic Valve Interstitial Cells
  46. Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a
  47. Directed reprogramming of comprehensively characterized dental pulp stem cells extracted from natal tooth
  48. Rapid Screening of the Endodermal Differentiation Potential of Human Pluripotent Stem Cells
  49. Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies
  50. Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification
  51. Future Challenges in the Generation of Hepatocyte-Like Cells From Human Pluripotent Stem Cells
  52. Development of an inducible platform for intercellular protein delivery
  53. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver
  54. Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines
  55. Small-Molecule-Directed Hepatocyte-Like Cell Differentiation of Human Pluripotent Stem Cells
  56. Chondrocytes Derived From Mesenchymal Stromal Cells and Induced Pluripotent Cells of Patients With Familial Osteochondritis Dissecans Exhibit an Endoplasmic Reticulum Stress Response and Defective Matrix Assembly
  57. Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
  58. Investigation of Rett syndrome using pluripotent stem cells
  59. Comment on "Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells"
  60. Modelling Human Disease with Pluripotent Stem Cells
  61. FUS-SMN Protein Interactions Link the Motor Neuron Diseases ALS and SMA
  62. Cellular reprogramming: a novel tool for investigating autism spectrum disorders
  63. Role of Pluripotent Stem Cells in Regenerative Medicine
  64. Regenerative Medicine, Stem Cells and the Liver
  65. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
  66. Humanized murine model for HBV and HCV using human induced pluripotent stem cells
  67. Lineage-specific distribution of high levels of genomic
  68. The evolving biology of cell reprogramming
  69. Biomedical and social contributions to sustainability
  70. Induced pluripotent stem cells: epigenetic memories and practical implications
  71. Hepatic Endoderm Differentiation from Human Embryonic Stem Cells
  72. What are the limits to cell plasticity?
  73. Generation of functional human hepatic endoderm from human induced pluripotent stem cells
  74. A decade of progress since the birth of Dolly
  75. UBF Binding In Vivo Is Not Restricted to Regulatory Sequences within the Vertebrate Ribosomal DNA Repeat
  76. Human acrocentric chromosomes with transcriptionally silent nucleolar organizer regions associate with nucleoli
  77. Dimerization and HMG box domains 1-3 present in Xenopus UBF are sufficient for its role in transcriptional enhancement
  78. The Xenopus RNA polymerase I transcription factor, UBF, has a role in transcriptional enhancement distinct from that at the promoter
  79. Nucleotide sequence of a repetitive element isolated from Leptospira interrogans serovar hardjo type hardjo-bovis
  80. Development of a PCR test specific for Leptospira hardjo genotype bovis